Unity’s own users have access to a range of interactive connections, including livestreams and discussions, to get the most out of the platform by finding out what other users are doing with it. It’s part of Unity’s overall commitment to providing transparency in the service.A short trip through Unity’s website shows that the company can offer a wide range of services, including 2D and 3D game creation, user acquisition apps so that creators can bring in an audience, and monetization apps that allow creator ...

NextGen Healthcare Chosen to Help Award-Winning ENT Practice Consolidate Vendors, Optimize WorkflowsFeb 17, 2026 8:35 AM Eastern Standard Time# NextGen Healthcare Chosen to Help Award- Winning ENT Practice Consolidate Vendors, Optimize WorkflowsShare---Ohio ENT & Allergy Physicians Reimagines Patient, Staff, and Provider Experience With Integrated SolutionsCOLUMBUS, Ohio-- ([BUSINESS WIRE])--NextGen Healthcare, a leading provider of innovative, cloud-based healthcare technology solutions, has been selected ...

Core Insights - Wolters Kluwer has announced the launch of Medi-Span Expert AI, aimed at enhancing medication intelligence for digital health technology developers [1] - The new Model Context Protocol (MCP) will facilitate the integration of AI-ready, expert-curated medication data into third-party applications, streamlining development processes [1] Group 1: Product Development and Features - Medi-Span Expert AI is designed to support various AI-driven workflows, including prescription renewals and medication verification, which are identified as the fastest-growing segments in healthcare [1] - The MCP server connects expert-curated drug content to AI workflows, enabling faster innovation and reducing complexity for digital health tech developers [1] - The solution aims to improve patient safety by providing robust drug dosing guidelines and advanced decision-making logic [1] Group 2: Market Context and Demand - There is a rising demand for automation in medication management, with healthcare providers seeking more efficient and reliable systems [1] - Current integration standards for drug information are not optimized for AI workflows, which can hinder innovation in the sector [1] - Wolters Kluwer's Medi-Span Expert AI is positioned to address these challenges by offering a dynamic format for drug content that is ready for AI applications [1] Group 3: Company Overview - Wolters Kluwer reported annual revenues of €5.9 billion for 2024 and operates in over 180 countries, employing approximately 21,600 people [1] - The company specializes in providing information, software solutions, and services across various sectors, including healthcare and technology [1]

Core Insights - Veradigm has launched a new patient-reported outcomes (PRO) survey capability that integrates patient insights into real-world evidence generation, enhancing the context of clinical and observational research [1] - The solution is built on Veradigm's FollowMyHealth platform, allowing patients to securely share their experiences, which helps life sciences organizations gain a holistic view of patient experiences and outcomes [1] - The integration of patient-reported information with existing real-world data provides a fuller picture of symptom burden, treatment experience, adherence, and quality-of-life factors [1] Company Overview - Veradigm is a leading provider of clinical and revenue cycle solutions for independent practices, with a focus on improving outcomes and financial performance [1] - The company has a proven history of delivering AI-forward data and technology solutions that connect over 20,000 provider practices with health plans and biopharma [1] - Veradigm's solutions are designed to eliminate inefficiencies, close care gaps, and create a more affordable health system [1] Product Features - The new PRO survey capability includes integrated consent and compensation to reduce friction in patient participation [1] - It employs precision outreach to relevant patient groups and ensures trusted engagement through an established patient platform [1] - The solution aims to provide connected clinical and patient input for richer context, capturing patient-centered insights often missing from clinical documentation [1]

Core Insights - GE HealthCare management will present at two upcoming investor conferences, including the Barclays 28th Annual Global Healthcare Conference on March 10, 2026, and Citi's 2026 Unplugged MedTech and Life Sciences Access Day on February 26, 2026 [1] Company Overview - GE HealthCare is a leading global healthcare solutions provider with a focus on advanced medical technology, pharmaceutical diagnostics, and AI, cloud, and software solutions [1] - The company has been operational for 130 years and is committed to delivering innovations aimed at enhancing personalized and precise patient care [1] - GE HealthCare operates as a $20.6 billion business with approximately 54,000 employees [1] Recent Developments - GE HealthCare has launched ReadyFix, a remote fleet management solution designed to enhance operational efficiency and device uptime in healthcare systems [1] - The company reported strong financial results for the fourth quarter and full year ended December 31, 2025, highlighting growth in Pharmaceutical Diagnostics, Imaging, and Advanced Visualization Solutions [1] - GE HealthCare's Allia Moveo has received U.S. FDA 510(k) clearance and CE Marking, marking a significant advancement in precision care within the interventional suite [1]

Group 1 - Evolent Health, Inc. (NYSE:EVH) is considered one of the best penny stocks to buy, despite a price target cut from Citi to $6 from $9.50 while maintaining a Buy rating, reflecting cautious optimism for 2026 amid a challenging 2025 [1] - Analysts at Citizens reiterated an Outperform rating on Evolent Health, lowering the price target to $10 from $11, indicating significant upside potential with an 11x multiple to the reduced EBITDA estimate of $154 million, down from $162 million [2] - The price target reduction is attributed to more conservative operating margin assumptions for 2026 to 2027, as the company faces potential erosion in Affordable Care Act membership this year [3] Group 2 - Evolent Health's fourth-quarter results are anticipated to provide insights into its strategic pivot towards specialty care, which is expected to enhance profitability [4] - The company has divested Evolent Care Partners to Privia Health Group to focus on core operations and reduce debt [4] - Evolent Health partners with health plans and providers to transition to value-based care, offering specialized clinical management, administrative simplification, and technology-driven solutions for high-cost patient populations [5]

Core Viewpoint - Medical Care Technologies Inc. is advancing its AI-powered wellness ecosystem by expanding into the Lifestyle and Wellness Application category, marking a significant shift from traditional medical applications to broader consumer health and wellness markets [1] Group 1 - The company is focusing on building a long-term wellness ecosystem powered by artificial intelligence [1] - The expansion into the Lifestyle and Wellness Application category signifies an important evolution of the company's platform [1] - This strategic initiative aims to scale the company's offerings beyond traditional medical applications [1]

Core Viewpoint - QScreen AI Inc. has officially changed its name from Predictmedix AI Inc. to better reflect its evolution into a broader screening and decision-intelligence platform, enhancing its market positioning and technology alignment [1][5][7]. Company Overview - QScreen AI Inc. is a provider of rapid health screening and remote patient care solutions globally, utilizing AI-powered Smarthealth AI stations to analyze physiological data and predict various health issues [8]. Name Change Details - The company's common shares will begin trading under the new symbol (CSE: QAI) on the Canadian Securities Exchange starting January 27, 2026, with no changes to share capital, business operations, or management [2][3][4]. Technological Evolution - The transition to QScreen AI Inc. signifies the company's advancement beyond traditional AI architectures, incorporating quantum-inspired and advanced computational techniques to enhance data processing and analysis [6][7]. Strategic Focus - The company aims to commercialize advanced, quantum-enhanced AI capabilities across healthcare, safety, and other high-value markets, with a focus on scaling and market penetration [7].

Core Insights - The Guangzhou Health Commission announced the launch of the AI medical assistant "Sui Xiao Yi" during the Greater Bay Area Healthcare Innovation Conference, which is now available on the Ant Financial's Aifu App [1][3] - Users can interact with "Sui Xiao Yi" via voice or text to access a full range of smart services including health consultations, intelligent appointment scheduling, waiting call numbers, medical insurance payments, and report inquiries and interpretations [1][3] - The online appointment and registration service through "Sui Xiao Yi" has already covered over 300 hospitals, including Guangzhou Medical University Affiliated Hospital and Southern Hospital, while the "cloud companion" service is available in more than 50 hospitals in Guangzhou [1][3] Industry Developments - Various city-level intelligent assistants, including Chongqing's "Yu Xiao Jian" and Guangzhou's "Sui Xiao Yi," have been integrated into the Ant Financial Aifu App to provide diverse services such as health consultations, appointment scheduling, cloud companionship, and report interpretations [1][3] - Additionally, the Aifu App has been designated as a "digital family doctor" cooperation platform in 10 regions, including Heilongjiang, Xinjiang, and Zhengzhou [1][3]

Core Insights - Wang Teng, a former executive at Xiaomi, has successfully completed a seed round financing for his startup "Today’s Rest," raising tens of millions of yuan with investments from GL Ventures, Zhiyuan Robotics, Xilinmen, and Yunjiu Capital [1][2] - The company plans to launch a series of hardware and software products in the second half of the year and aims to expand internationally [1] - The product development will focus on brain science and artificial intelligence, aiming to reduce cognitive costs and enhance individual sleep and energy states [1] Company Overview - "Today’s Rest" is not merely defined as a smart bed or sleep monitoring device but introduces a long-term concept of "energy asset management," viewing human energy as a core asset that is often overlooked [1] - The company intends to evolve its product offerings based on technological capabilities and user needs, targeting tech-driven categories to create a closed-loop solution for energy perception, state adjustment, and long-term management [1] Leadership Background - Wang Teng was previously recognized as a promising talent at Xiaomi, holding positions such as General Manager of the REDMI brand and later as General Manager of Xiaomi's China marketing department [2] - His notable contributions at Xiaomi include the development of products like Mix2, Xiaomi 8, and Redmi Note 7 [2] - Following a dismissal from Xiaomi due to serious violations, Wang expressed regret and gratitude towards the company while announcing his entrepreneurial venture [2]